|
World Vaccine Congress Asia 2008 is Asia's Number 1 Vaccine Congress!
It is even BIGGER and BETTER this year ...
There is no doubt that Asia's vaccine industry is growing at an enormous speed. Not only are foreign vaccine companies actively expanding into this region to get a share of the pie, more and more local vaccine manufacturers are upgrading their facilities and getting ready to go global.
- Do you have what it takes to stay ahead of the competition in Asia's burgeoning vaccine market?
- Are you concerned about the challenges and competition in the region?
- If you are one of the local vaccine players who are eager to reach out to the global market, what are the practical strategies and approached that you should adopt?
>> View World Vaccine Congress Asia 2008 program
|
Hear vaccine updates
|
 Be inspired by industry leaders |
|
Backed by the resounding success last year, the highly anticipating World Vaccine Congress Asia 2008 is here to have all your questions answered by top industry leaders!
Meet vaccine experts from NGOs (eg. Bill & Melinda Gates, PATH, WHO, IVI) and top vaccine companies such as Green Cross, 9Bio, Novartis, Intercell, Dynavax, sanofi pasteur, CNBG, AdImmune, NasVax, Vaxine, Serum Institute of India, IVAC, Shantha Biotechnics, Panacea Biotec and more!
World Vaccine Congress Asia 2008 is an annual meeting place where vaccine buyers and sellers, health authorities, financing institutions, regulators, big and small vaccine producers and manufacturers, technology providers and other stakeholders come together to discuss industry trend, market and partnership opportunities, new vaccines and new technology innovations across Asia!
|
|
|
Gain industry knowledge
Building future networks
|
Read what others said about 2007
"A wonderful effort in gathering the players in the Asia vaccine industry together for an intensive 2-day Congress! We were pleased to contact several companies from the region and have the opportunity to showcase our strengths across Asia Pacific. Quintiles looks forward to an even bigger gathering next year!"
Quintiles
"The Congress was well organized and helped provide an opportunity scan for technocrats and service providers, in terms of discussing the market needs and drivers that make the vaccine industry vibrant".
Millipore
"Excellent presentations on the myriad of activities in Asia and excellent opportunities to meet up with potential and existing customers"
BD Pharmaceutical Systems
Reserve your seat now
|
|
|
|
|
|
Choose your language
Adel Mahmoud
Former President, Merck Vaccines, USA
Klaus Stohr
Director, Influenza Vaccine Franchises, Novartis Vaccines & Diagnostics, USA
Debra Kristensen
Senior Technical Officer,
PATH, USA
Xiaofeng Liang
Director, Chinese CDC & Prevention, National Immunisation Programme, China
Chong-Hwan Chang
Vice President,
Head of R&D,
Green Cross, Korea
|
|
|
